J. Thistlethwaite to Kidney Transplantation
This is a "connection" page, showing publications J. Thistlethwaite has written about Kidney Transplantation.
Connection Strength
6.612
-
Gender and race/ethnicity differences in living kidney donor demographics: Preference or disparity? Transplant Rev (Orlando). 2021 07; 35(3):100614.
Score: 0.488
-
Living Donation by Individuals with Life-Limiting Conditions. J Law Med Ethics. 2019 03; 47(1):112-122.
Score: 0.422
-
Introducing Genetic Tests With Uncertain Implications in Living Donor Kidney Transplantation: ApoL1 as a Case Study. Prog Transplant. 2016 Sep; 26(3):203-6.
Score: 0.349
-
Racial disparities in reaching the renal transplant waitlist: is geography as important as race? Clin Transplant. 2015 Jun; 29(6):531-8.
Score: 0.323
-
Outcomes after kidney donation. JAMA. 2014 Jul 02; 312(1):94.
Score: 0.305
-
Age should not be considered in the allocation of deceased donor kidneys. Semin Dial. 2012 Nov-Dec; 25(6):675-81.
Score: 0.271
-
Equal Opportunity Supplemented by Fair Innings: equity and efficiency in allocating deceased donor kidneys. Am J Transplant. 2012 Aug; 12(8):2115-24.
Score: 0.265
-
Long-term consequences of kidney donation. N Engl J Med. 2009 May 28; 360(22):2371; author reply 2372.
Score: 0.214
-
Potential inefficiency of a proposed efficiency model for kidney allocation. Am J Kidney Dis. 2008 Apr; 51(4):545-8.
Score: 0.198
-
We need a registry of living kidney donors. Hastings Cent Rep. 2007 Nov-Dec; 37(6):1 p following 48.
Score: 0.192
-
Shared decision making in deceased-donor transplantation. Lancet. 2006 Jul 22; 368(9532):333-7.
Score: 0.176
-
Kidney transplantation: graft monitoring and immunosuppression. World J Surg. 2002 Feb; 26(2):185-93.
Score: 0.128
-
Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group. Transplantation. 2000 Sep 15; 70(5):784-90.
Score: 0.117
-
Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection. Transplantation. 1999 Sep 15; 68(5):608-16.
Score: 0.109
-
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity. Am J Kidney Dis. 1999 Jul; 34(1):69-84.
Score: 0.108
-
Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience. Transplant Proc. 1998 Jun; 30(4):1369-70.
Score: 0.100
-
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Jun; 30(4):1538-40.
Score: 0.100
-
Synchronous pancreas-kidney transplantation with portal venous and enteric exocrine drainage: outcome in 70 consecutive cases. Transplant Proc. 1998 Mar; 30(2):270-1.
Score: 0.098
-
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. Transplant Proc. 1998 Mar; 30(2):507-8.
Score: 0.098
-
Reversal of accelerated renal allograft rejection with FK 506. Clin Transplant. 1997 Aug; 11(4):251-4.
Score: 0.094
-
Kidney Donor Profile Index Does Not Accurately Predict the Graft Survival of Pediatric Deceased Donor Kidneys. Transplantation. 2016 Nov; 100(11):2471-2478.
Score: 0.090
-
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. Transplantation. 1996 Oct 15; 62(7):906-10.
Score: 0.089
-
Attitudes of Lay Stakeholders and Transplant Professionals About Disclosure to Living Kidney Donors in Exchanges and Chains. Prog Transplant. 2016 Dec; 26(4):299-308.
Score: 0.089
-
Long-term outcome of kidney-pancreas transplant recipients with good graft function at one year. Transplantation. 1996 Aug 27; 62(4):451-6.
Score: 0.089
-
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Clin Transplant. 1996 Aug; 10(4):323-32.
Score: 0.088
-
OKT3 escalating dose regimens provide effective therapy for renal allograft rejection. Clin Transplant. 1996 Aug; 10(4):389-95.
Score: 0.088
-
Late complications in kidney-pancreas transplant recipients. Transplant Proc. 1995 Dec; 27(6):3118.
Score: 0.084
-
Disclosing Health and Health Behavior Information between Living Donors and Their Recipients. Clin J Am Soc Nephrol. 2015 Sep 04; 10(9):1609-16.
Score: 0.082
-
Changes in urinary cytokine mRNA profile after successful therapy for acute cellular renal allograft rejection. Transplant Proc. 1995 Feb; 27(1):887-9.
Score: 0.079
-
The recurrence of recurrent membranous glomerulopathy in a renal transplant recipient: case report and literature review. Am J Kidney Dis. 1994 Nov; 24(5):873-8.
Score: 0.078
-
OKT3 induction in pediatric renal transplantation. Pediatr Nephrol. 1993 Feb; 7(1):45-9.
Score: 0.069
-
Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation. Diabetes. 1992 Oct; 41(10):1346-54.
Score: 0.068
-
Risk, prognosis, and unintended consequences in kidney allocation. N Engl J Med. 2011 Apr 07; 364(14):1285-7.
Score: 0.061
-
The use of the T-cell flow cytometry crossmatch to evaluate the significance of positive B-cell serologic crossmatches in cadaveric donor renal transplantation. Transplant Proc. 1990 Aug; 22(4):1897-8.
Score: 0.058
-
Changing attitudes toward influenza vaccination in U.S. Kidney transplant programs over the past decade. Clin J Am Soc Nephrol. 2010 Sep; 5(9):1637-41.
Score: 0.058
-
Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients. Am J Kidney Dis. 1989 Nov; 14(5 Suppl 2):28-34.
Score: 0.055
-
Percapsular and percutaneous embolization of renal transplant pseudoaneurysm and AV fistula: case report. Cardiovasc Intervent Radiol. 1989 Sep-Oct; 12(5):270-3.
Score: 0.055
-
Aggressive needle biopsy protocol prevents loss of renal allografts to undetected rejection during early posttransplant dysfunction. Transplant Proc. 1989 Feb; 21(1 Pt 2):1890-2.
Score: 0.052
-
Stress conditioning: a novel approach to organ preservation. Curr Surg. 1989 Jan-Feb; 46(1):23-6.
Score: 0.052
-
Use of a brief steroid trial before initiating OKT3 therapy for renal allograft rejection. Am J Kidney Dis. 1988 Feb; 11(2):94-8.
Score: 0.049
-
T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation. Transplant Proc. 1987 Feb; 19(1 Pt 1):722-4.
Score: 0.046
-
The use of OKT3 to treat steroid-resistant renal allograft rejection in patients receiving cyclosporine. Transplant Proc. 1987 Feb; 19(1 Pt 3):1901-4.
Score: 0.046
-
OKT3 treatment of steroid-resistant renal allograft rejection. Transplantation. 1987 Feb; 43(2):176-84.
Score: 0.046
-
Attitudes of minority patients with end-stage renal disease regarding ABO-incompatible list-paired exchanges. Am J Transplant. 2006 Jan; 6(1):83-8.
Score: 0.042
-
Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation. Hum Immunol. 1985 Nov; 14(3):314-23.
Score: 0.042
-
Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection. Transplantation. 2005 Jan 27; 79(2):228-35.
Score: 0.040
-
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss. Transplantation. 2004 Oct 27; 78(8):1233-6.
Score: 0.039
-
Platelets and capillary injury in acute humoral rejection of renal allografts. Hum Pathol. 2003 Jun; 34(6):533-40.
Score: 0.035
-
Should all living donors be treated equally? Transplantation. 2002 Aug 15; 74(3):418-21; discussion 421-2.
Score: 0.033
-
Successful retransplantation after renal allograft loss to polyoma virus interstitial nephritis. Transplantation. 2002 Apr 15; 73(7):1166-9.
Score: 0.033
-
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies. Hum Pathol. 2001 Feb; 32(2):205-15.
Score: 0.030
-
Combined liver and kidney transplantation in children. Transplantation. 2000 Jul 15; 70(1):100-5.
Score: 0.029
-
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group. Transplantation. 1999 Oct 27; 68(8):1117-24.
Score: 0.028
-
Drug-induced acute interstitial nephritis in renal allografts: histopathologic features and clinical course in six patients. Am J Kidney Dis. 1999 Sep; 34(3):540-8.
Score: 0.027
-
The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies. J Am Soc Nephrol. 1999 Aug; 10(8):1806-14.
Score: 0.027
-
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach. Transplant Proc. 1998 Jun; 30(4):1234-5.
Score: 0.025
-
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression. Transplant Proc. 1998 Jun; 30(4):1378-9.
Score: 0.025
-
Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol. 1998 Apr; 9(4):677-83.
Score: 0.025
-
Ethics of a paired-kidney-exchange program. N Engl J Med. 1997 Jun 12; 336(24):1752-5.
Score: 0.023
-
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal. Transplant Proc. 1997 Feb-Mar; 29(1-2):307.
Score: 0.023
-
Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. Transplant Proc. 1996 Dec; 28(6):3163-4.
Score: 0.023
-
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group. Transplantation. 1996 Sep 15; 62(5):594-9.
Score: 0.022
-
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506. Transplant Proc. 1996 Apr; 28(2):998-9.
Score: 0.022
-
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival. Kidney Int. 1996 Mar; 49(3):768-72.
Score: 0.021
-
Pancreas transplantation with portal venous drainage and enteric exocrine drainage offers early advantages without compromising safety or allograft function. Transplant Proc. 1995 Dec; 27(6):3002-3.
Score: 0.021
-
To tell or not to tell: attitudes of transplant surgeons and transplant nephrologists regarding the disclosure of recipient information to living kidney donors. Clin Transplant. 2015 Dec; 29(12):1203-12.
Score: 0.021
-
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. A randomized controlled trial. Ann Intern Med. 1995 Jul 01; 123(1):18-26.
Score: 0.020
-
OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studies. Transplant Proc. 1995 Feb; 27(1):852-3.
Score: 0.020
-
A K-nearest neighbors survival probability prediction method. Stat Med. 2013 May 30; 32(12):2062-9.
Score: 0.018
-
A randomized clinical trial of induction therapy with OKT3 in kidney transplantation. Transplantation. 1993 Jan; 55(1):44-50.
Score: 0.017
-
Elevated lipoprotein(a) levels in renal transplantation and hemodialysis patients. Am J Nephrol. 1991; 11(6):470-4.
Score: 0.015
-
Laser Doppler blood flow measurement as a predictor of viability of renal allografts. Curr Surg. 1990 Nov-Dec; 47(6):431-2.
Score: 0.015
-
Effect of discontinuing or restricting cyclosporine on late renal allograft rejection and function. Transplant Proc. 1989 Feb; 21(1 Pt 2):1641-2.
Score: 0.013
-
Complications and monitoring of OKT3 therapy. Am J Kidney Dis. 1988 Feb; 11(2):112-9.
Score: 0.012
-
Reexposure to OKT3 in renal allograft recipients. Transplantation. 1988 Feb; 45(2):349-53.
Score: 0.012
-
Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts. Am Surg. 1987 Jul; 53(7):407-9.
Score: 0.012
-
An immunosuppressive protocol compatible with the United States kidney transplant diagnosis related grouping. Transplant Proc. 1987 Feb; 19(1 Pt 3):1959-60.
Score: 0.011
-
Intermediate normothermic hemoperfusion doubles safe cold preservation of rat kidneys. Transplant Proc. 1987 Feb; 19(1 Pt 2):1369-71.
Score: 0.011
-
Potent immunosuppression overcomes retransplantation, presensitization, and historical positive crossmatch as transplant risk factors. Transplant Proc. 1987 Feb; 19(1 Pt 3):1915-6.
Score: 0.011
-
Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation. 1984 Dec; 38(6):695-701.
Score: 0.010
-
Effect of class II antigen matching on renal allograft survival in miniature swine. J Exp Med. 1984 Nov 01; 160(5):1495-508.
Score: 0.010
-
Transplantation in miniature swine. X. Evidence for non-SLA-linked immune response gene(s) controlling rejection of SLA-matched kidney allografts. Transplantation. 1981 Oct; 32(4):315-20.
Score: 0.008
-
Imaging of pancreatic transplantation using portal venous and enteric exocrine drainage. AJR Am J Roentgenol. 1998 Jul; 171(1):157-63.
Score: 0.006
-
Bone allografts are immunogenic and may preclude subsequent organ transplants. Clin Orthop Relat Res. 1997 Jul; (340):215-9.
Score: 0.006